AstraZeneca’s newly acquired Soliris is overpriced in myasthenia gravis, cost watchdog says

Now that Alexion’s Soliris is in AstraZeneca’s hands, the drugmaker is counting on the C5 inhibitor to help push it toward billions in sales in just a few years. But a prominent drug pricing watchdog is raising a red flag over its costs for patients with a rare neuromuscular disorder.  The Institute for Clinical and… Read More »

What should happen to our data when we die?

Using several hours of Bourdain’s voice recordings, a software company created 45 seconds of new audio for the documentary. The AI voice sounds just like Bourdain speaking from the great beyond; at one point in the movie, it reads an email he sent before his death by suicide in 2018. “If you watch the film,… Read More »